盛利波 王郑党
[摘要] 目的 分析奈韦拉平和依非韦伦在艾滋治疗的应用效果。方法 在该院2015年7月—2017年7月期间诊疗的艾滋病患者中,随机抽取100例患者纳入该研究。按照随机数字表法将患者分为A组50例、B组50例,即A组患者给予奈韦拉平治疗,B组患者给予依非韦伦治疗,比较两组患者治疗效果。 结果 A组患者治疗总有效率和B组患者较为相似,即88.00%、96.00%,两组患者各数据间对比差异无统计学意义(χ2=2.173 9,P=0.140 3)。治疗前后,两组患者CD4细胞计数较为相似,即两组患者各数据间對比差异无统计学意义,如治疗前,A组患者CD4细胞计数为(112±63)个/L,B组患者CD4细胞计数为(107±72)个/L(t=0.369 5,P=0.712 5);治疗24周,A组患者CD4细胞计数为(156±53)个/L,B组患者CD4细胞计数为(150±55)个/L(t=0.555 4,P=0.579 8)。B组患者消化道症状、肝功能异常、皮疹等不良反应较低于A组,但中枢神经障碍不良反应率高于A组,即B组患者总不良反应率为12.00%,A组患者总不良反应率为28.00%,即两组患者各数据间对比差异有统计学意义(χ2=4.000 0,P=0.045 5)。结论 在艾滋病患者救治中,虽然奈韦拉平、依非韦伦药物免疫效果较为相似,但不良反应则各具特点,应依据患者病情需要,选择适宜的治疗药物,方可提高治疗效果。
[关键词] 奈韦拉平;依非韦伦;艾滋病
[中图分类号] R512 [文献标识码] A [文章编号] 1674-0742(2018)05(a)-0019-03
Analysis of Application of Nevirapine and Efavirenz in Treatment of AIDS
SHENG Li-bo1, WANG Zheng-dang2
1.Department of Internal Medicine, Central Hospital of Yunnan Prison Administration, Kunming, Yunnan Province, 650216 China;2.Department of Internal Medicine, Songming Prison Hospital, Songming, Yunnan Province, 651703 China
[Abstract] Objective To analyze the application effect of nevirapine and efavirenz in treatment of AIDS. Methods 100 cases of AIDS patients admitted and treated in our hospital from July 2015 to July 2017 were selected and randomly divided into two groups with 50 cases in each, the group A and the group B were respectively treated with nevirapine and efavirenz, and the treatment effect was compared between the two groups. Results The total treatment effective rate in the group A was similar to that in the group B, namely 88.00%, 96.00%, and the difference between groups was not statistically significant (χ2=2.173 9, P=0.140 3) , and the CD4 cell count between the two groups before and after treatment was similar, and the difference was not statistically significant, and the CD4 cell count in the group A and in the group B was respectively (112±63) /L and (107±72) /L,(t=0.369 5, P=0.712 5), after 24-week treatment, the CD4 cell count in the group A and in the group B was respectively(156±53) /L and (150±55) /L,(t=0.555 4, P=0.579 8), and the adverse reactions were lower than those in the group A, and the adverse reaction rate of central nervous disorder was higher than that in the group A, namely the total adverse reaction rate in the group B and in the group A was respectively 12.00% and 28.00%, and the difference was statistically significant (χ2=4.000 0, P=0.045 5). Conclusion The immune effect of nevirapine and efavirenz in treatment of AIDS is similar, but the adverse reactions have their own features, and we should select the proper treatment drugs according to the disease needs, thus improving the treatment effect.
[Key words] Nevirapine; Efavirenz; AIDS
奈韦拉平、依非韦伦作为艾滋病患者首选药物,是非核苷类反转录酶抑制剂。但是,在实际使用期间,患者多存在不同程度的药物不良反应,甚至会在危及脏器的条件下,引发各类机体不适。而这也会使部分患者难以遵医嘱用药,如自行停药现象的出现,不仅对药物抗毒效果产生威胁,还会呈现机体耐药性[1-2]。……